Accuryn Medical Achieves Notable Sales Milestone
Accuryn Medical is proud to announce a remarkable achievement in the healthcare sector with the shipment of over 100,000 SmartFoley catheters throughout the United States. This milestone is not just a number; it signifies the commitment and dedication Accuryn has toward addressing acute kidney injury (AKI) through innovative solutions in renal monitoring.
The Impact of the Accuryn SmartFoley Catheter
At the heart of this accomplishment is the Accuryn SmartFoley catheter, which doubles as a next-generation sensor. This catheter is part of the Accuryn Monitoring System, designed to deliver real-time renal assessment based on established clinical guidelines. Its integration into over 70 hospitals across the country demonstrates its growing acceptance among healthcare providers.
Transforming Patient Care
Accuryn's technology revolutionizes the traditional Foley catheter, converting it into a powerful tool that not only aids in care but also enhances the workflow of healthcare professionals. This system enables clinicians to automate clinical data collection, allowing them to visualize trends and patterns swiftly. By delivering critical insights, healthcare providers can make timely decisions to improve patient outcomes.
Addressing Hospital Acquired Infections
The implications of prolonged hospital stays often result from complications like hospital-acquired infections. Many of these issues are preventable, yet the manual monitoring required for kidney function can slow diagnosis and treatment. The Accuryn Monitoring System changes this narrative by offering automated, real-time data concerning urine output, intra-abdominal pressure, and body temperature. This advancement not only supports goal-directed treatment but also facilitates critical decision-making for clinicians caring for seriously ill patients.
Statistics on Acute Kidney Injury
Acute kidney injury remains a pressing issue in healthcare, with nearly 42% of patients admitted to intensive care units experiencing some form of kidney injury. Those affected are at a greater risk of developing additional complications even after discharge. The Accuryn SmartFoley catheter stands out by minimizing margin for error through its patented DrainLine Clearance. This innovative feature enhances the monitoring of urine output and detects AKI following KDIGO guidelines—much earlier than conventional methods.
About Accuryn Medical
Accuryn Medical, Inc. is resolutely focused on addressing AKI through its pioneering real-time renal monitoring system. Their goal is simple yet impactful: to enable early interventions that can significantly reduce preventable mortality and morbidity related to kidney injuries. Headquartered in Hayward, CA, Accuryn Medical continues to seek advancement in healthcare technology for the betterment of patient care.
Connecting with Accuryn Medical
For anyone seeking further insights into Accuryn’s innovative solutions in renal monitoring, the official website offers extensive resources and information about their products and services. This commitment to education and transparency highlights the company's dedication to improving kidney health.
Frequently Asked Questions
What milestone has Accuryn Medical achieved recently?
Accuryn Medical recently celebrated the shipping of over 100,000 SmartFoley catheters across the United States.
What is the purpose of the Accuryn SmartFoley catheter?
The Accuryn SmartFoley catheter is designed to provide real-time monitoring of kidney function, helping clinicians manage patient care more effectively.
How does the Accuryn Monitoring System assist healthcare providers?
This system automates the collection of clinical data, enabling healthcare professionals to visualize trends and respond to patients' needs promptly.
What complications can arise from acute kidney injury?
AKI can lead to increased mortality rates, prolonged hospital stays, and elevated healthcare costs due to complications and hospital-acquired infections.
How is Accuryn Medical contributing to kidney health?
The company is committed to tackling AKI through innovative solutions that provide real-time data, enabling early interventions and potentially reducing preventable complications.
